Samyn M E, Petershack J A, Bedell K A, Mathews M S, Segar J L
Department of Pediatrics and the Cardiovascular Center, University of Iowa, Iowa City 52242, USA.
Pediatr Res. 1998 Sep;44(3):323-9. doi: 10.1203/00006450-199809000-00010.
Previous studies have shown that the expression of cardiac angiotensin II (ANG II) type 1 (AT1) and type 2 (AT2) receptors are developmentally regulated, although factors modulating these receptors have not been well investigated. The present study was designed 1) to characterize the ontogeny of cardiac AT1 and AT2 gene expression during the last third trimester of gestation in fetal sheep and newborn lambs, 2) to determine the influence of ANG II on modulating cardiac AT1 and AT2 gene expression during fetal life, and 3) to investigate the role of AT1 receptor activity on the regulation of AT1 and AT2 mRNA levels during fetal cardiac development. Using sheep AT1 and AT2 cDNA probes, we demonstrated that cardiac AT1 gene expression is relatively unchanged during fetal (90-135 d of gestation, term 145 d) and newborn life. In contrast, cardiac AT2 mRNA expression was high during fetal development and decreased rapidly after birth. Continuous i.v. infusion of ANG II (9.5 nM/h) for 24 h, which raised ANG II levels from 84+/-9 to 210+/-21 pg/mL had no effect on the expression of cardiac AT1 or AT2 mRNA, but increased adrenal and decreased liver AT1 mRNA levels. Administration of the AT1 receptor antagonist losartan (1.2 mg kg(-1) h(-1)) significantly decreased arterial blood pressure in fetuses at 110- and 135-d, but not 95-d gestation. Except for increased AT1 receptor gene expression in the right atrium at 95- and 135-d gestation, and left ventricle at 110-d gestation, cardiac AT1 and AT2 mRNA levels were unaltered by AT1 receptor blockade. In summary, this study demonstrates that cardiac AT2 but not AT1 receptor gene expression is regulated by the transition from fetal to newborn life. Neither ANG II nor blockade of AT1 receptors significantly alter the expression of AT1 or AT2 mRNA in the fetal heart. Endogenous ANG II also appears to significantly contribute to the maintenance of blood pressure homeostasis during the final third of gestation in fetal lambs.
以往研究表明,心脏血管紧张素II(ANG II)1型(AT1)和2型(AT2)受体的表达受发育调控,尽管调节这些受体的因素尚未得到充分研究。本研究旨在:1)描述胎羊和新生羔羊妊娠最后三个月心脏AT1和AT2基因表达的个体发生过程;2)确定ANG II在胎儿期对心脏AT1和AT2基因表达的调节作用;3)研究AT1受体活性在胎儿心脏发育过程中对AT1和AT2 mRNA水平调节的作用。使用绵羊AT1和AT2 cDNA探针,我们发现心脏AT1基因表达在胎儿期(妊娠90 - 135天,足月为145天)和新生儿期相对不变。相比之下,心脏AT2 mRNA表达在胎儿发育期间较高,出生后迅速下降。连续静脉输注ANG II(9.5 nM/h)24小时,使ANG II水平从84±9升高至210±21 pg/mL,对心脏AT1或AT2 mRNA的表达无影响,但增加了肾上腺AT1 mRNA水平并降低了肝脏AT1 mRNA水平。给予AT1受体拮抗剂氯沙坦(1.2 mg kg⁻¹ h⁻¹)可显著降低妊娠110天和135天胎儿的动脉血压,但对妊娠95天胎儿无此作用。除了在妊娠95天和135天右心房以及妊娠110天左心室中AT1受体基因表达增加外,AT1受体阻断对心脏AT1和AT2 mRNA水平无影响。总之,本研究表明,从胎儿期到新生儿期的转变可调节心脏AT2而非AT1受体基因的表达。ANG II和AT1受体阻断均未显著改变胎儿心脏中AT1或AT2 mRNA的表达。内源性ANG II似乎也对胎羊妊娠最后三个月血压稳态的维持有显著贡献。